Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/28/16 → 6/28/19 |
Funding
- Chiltern International, Inc. (Prot# AC-065A308 // Prot# AC-065A308)
- Actelion Pharmaceuticals Ltd. (Prot# AC-065A308 // Prot# AC-065A308)
Prot #AC-065A308: The efficacy and safety of initial triple versus initial dual oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: A multi-center, double-blind, placebo-controlled, Phase 3b study
- Cajigas, Hector R (PD/PI)
Project: Research project